PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancer
Prat, A. (Universitat Autònoma de Barcelona. Departament de Medicina)
Parker, J. S. (Lineberger Comprehensive Cancer Center, University of North Carolina, CB# 7295, Chapel Hill, NC 27599 USA)
Fan, C. (Lineberger Comprehensive Cancer Center, University of North Carolina, CB# 7295, Chapel Hill, NC 27599 USA)
Perou, Charles M. (Department of Pathology & Laboratory Medicine, University of North Carolina, Chapel Hill, NC USA)

Date:	2012
Abstract:	The online version of this article (doi:10. 1007/s10549-012-2143-0) contains supplementary material, which is available to authorized users.
Note:	Altres ajuts: This study was supported by funds from the NCI Breast SPORE Program (P50-CA58223-09A1), by RO1-CA138255, by the Breast Cancer Research Foundation, and the Sociedad Española de Oncología Médica (SEOM). A. Prat is affiliated to the Medicine PhD Program of the Autonomous University of Barcelona (UAB), Spain.
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Language:	Anglès
Document:	Article ; recerca ; Versió publicada
Subject:	Breast cancer ; Microarrays ; PAM50 ; Prognosis ; Gene expression
Published in:	Breast Cancer Research and Treatment, Vol. 135 (july 2012) , p. 301-306, ISSN 1573-7217

DOI: 10.1007/s10549-012-2143-0
PMID: 22752290

6 p, 394.6 KB

The record appears in these collections:
Articles > Research articles
Articles > Published articles